208 related articles for article (PubMed ID: 19687016)
1. Calcium-channel blockers decrease clopidogrel-mediated platelet inhibition.
Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
Heart; 2010 Feb; 96(3):186-9. PubMed ID: 19687016
[TBL] [Abstract][Full Text] [Related]
2. Comparison of methods to evaluate clopidogrel-mediated platelet inhibition after percutaneous intervention with stent implantation.
Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
Thromb Haemost; 2009 Feb; 101(2):333-9. PubMed ID: 19190818
[TBL] [Abstract][Full Text] [Related]
3. Calcium-channel blockers reduce the antiplatelet effect of clopidogrel.
Siller-Matula JM; Lang I; Christ G; Jilma B
J Am Coll Cardiol; 2008 Nov; 52(19):1557-63. PubMed ID: 19007592
[TBL] [Abstract][Full Text] [Related]
4. The influencing factors for clopidogrel-mediated platelet inhibition are assay-dependent.
Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
Thromb Res; 2011 Oct; 128(4):352-7. PubMed ID: 21621250
[TBL] [Abstract][Full Text] [Related]
5. Smoking promotes clopidogrel-mediated platelet inhibition in patients receiving dual antiplatelet therapy.
Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
Thromb Res; 2009 Nov; 124(5):588-91. PubMed ID: 19631365
[TBL] [Abstract][Full Text] [Related]
6. The use of amlodipine, but not of P-glycoprotein inhibiting calcium channel blockers is associated with clopidogrel poor-response.
Harmsze AM; Robijns K; van Werkum JW; Breet NJ; Hackeng CM; Ten Berg JM; Ruven HJ; Klungel OH; de Boer A; Deneer VH
Thromb Haemost; 2010 May; 103(5):920-5. PubMed ID: 20352154
[TBL] [Abstract][Full Text] [Related]
7. Monitoring platelet inhibition after clopidogrel with the VerifyNow-P2Y12(R) rapid analyzer: the VERIfy Thrombosis risk ASsessment (VERITAS) study.
Malinin A; Pokov A; Spergling M; Defranco A; Schwartz K; Schwartz D; Mahmud E; Atar D; Serebruany V
Thromb Res; 2007; 119(3):277-84. PubMed ID: 16563469
[TBL] [Abstract][Full Text] [Related]
8. Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention: is the current antiplatelet therapy adequate?
Bliden KP; DiChiara J; Tantry US; Bassi AK; Chaganti SK; Gurbel PA
J Am Coll Cardiol; 2007 Feb; 49(6):657-66. PubMed ID: 17291930
[TBL] [Abstract][Full Text] [Related]
9. Calcium-Channel Blockers Attenuate the Antiplatelet Effect of Clopidogrel.
Gremmel T; Durstberger M; Eichelberger B; Koppensteiner R; Panzer S
Cardiovasc Ther; 2015 Oct; 33(5):264-9. PubMed ID: 26014752
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up.
Marcucci R; Gori AM; Paniccia R; Giusti B; Valente S; Giglioli C; Buonamici P; Antoniucci D; Abbate R; Gensini GF
Circulation; 2009 Jan; 119(2):237-42. PubMed ID: 19118249
[TBL] [Abstract][Full Text] [Related]
11. The influence of proton pump inhibitors on the antiplatelet potency of clopidogrel evaluated by 5 different platelet function tests.
Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
J Cardiovasc Pharmacol; 2010 Nov; 56(5):532-9. PubMed ID: 20729752
[TBL] [Abstract][Full Text] [Related]
12. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis.
Sibbing D; Braun S; Morath T; Mehilli J; Vogt W; Schömig A; Kastrati A; von Beckerath N
J Am Coll Cardiol; 2009 Mar; 53(10):849-56. PubMed ID: 19264241
[TBL] [Abstract][Full Text] [Related]
13. Impact of the degree of peri-interventional platelet inhibition after loading with clopidogrel on early clinical outcome of elective coronary stent placement.
Hochholzer W; Trenk D; Bestehorn HP; Fischer B; Valina CM; Ferenc M; Gick M; Caputo A; Büttner HJ; Neumann FJ
J Am Coll Cardiol; 2006 Nov; 48(9):1742-50. PubMed ID: 17084243
[TBL] [Abstract][Full Text] [Related]
14. Predictive values of post-treatment adenosine diphosphate-induced aggregation and vasodilator-stimulated phosphoprotein index for stent thrombosis after acute coronary syndrome in clopidogrel-treated patients.
Cuisset T; Frere C; Quilici J; Gaborit B; Castelli C; Poyet R; Bali L; Morange PE; Alessi MC; Bonnet JL
Am J Cardiol; 2009 Oct; 104(8):1078-82. PubMed ID: 19801028
[TBL] [Abstract][Full Text] [Related]
15. Impact of anemia on platelet response to clopidogrel in patients undergoing percutaneous coronary stenting.
Toma C; Zahr F; Moguilanski D; Grate S; Semaan RW; Lemieux N; Lee JS; Cortese-Hassett A; Mulukutla S; Rao SV; Marroquin OC
Am J Cardiol; 2012 Apr; 109(8):1148-53. PubMed ID: 22277895
[TBL] [Abstract][Full Text] [Related]
16. Light transmittance aggregometry induced by different concentrations of adenosine diphosphate to monitor clopidogrel therapy: a methodological study.
Paniccia R; Antonucci E; Maggini N; Miranda M; Romano E; Gori AM; Marcucci R; Prisco D; Abbate R
Ther Drug Monit; 2011 Feb; 33(1):94-8. PubMed ID: 21192314
[TBL] [Abstract][Full Text] [Related]
17. Clopidogrel response status assessed with Multiplate point-of-care analysis and the incidence and timing of stent thrombosis over six months following coronary stenting.
Sibbing D; Morath T; Braun S; Stegherr J; Mehilli J; Vogt W; Schömig A; Kastrati A; von Beckerath N
Thromb Haemost; 2010 Jan; 103(1):151-9. PubMed ID: 20062919
[TBL] [Abstract][Full Text] [Related]
18. Functional impact of high clopidogrel maintenance dosing in patients undergoing elective percutaneous coronary interventions. Results of a randomized study.
Angiolillo DJ; Bernardo E; Palazuelos J; Desai B; Weisberg I; Alfonso F; Guzman LA; Hernández-Antolin R; Zenni MZ; Macaya C; Fernandez-Ortiz A; Bass TA
Thromb Haemost; 2008 Jan; 99(1):161-8. PubMed ID: 18217149
[TBL] [Abstract][Full Text] [Related]
19. Assessment of VerifyNow P2Y12 assay accuracy in evaluating clopidogrel-induced platelet inhibition.
Lordkipanidzé M; Pharand C; Nguyen TA; Schampaert E; Diodati JG
Ther Drug Monit; 2008 Jun; 30(3):372-8. PubMed ID: 18520610
[TBL] [Abstract][Full Text] [Related]
20. Adenosine diphosphate-inducible platelet reactivity shows a pronounced age dependency in the initial phase of antiplatelet therapy with clopidogrel.
Gremmel T; Steiner S; Seidinger D; Koppensteiner R; Panzer S; Kopp CW
J Thromb Haemost; 2010 Jan; 8(1):37-42. PubMed ID: 19818001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
